Oxytocin and group therapy for schizophrenia
Treatments studied
Part of Mental health clinical trials.
This trial tests whether adding oxytocin (a hormone that helps with social bonding) to group therapy can improve symptoms and social functioning in people with schizophrenia. It compares two different doses of oxytocin to see which works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia or a related condition (like schizoaffective disorder).
- You have mild to moderate symptoms (not severe).
- You speak German fluently (native or near-native).
- Your psychiatric medications have been stable (no changes) for at least 2 weeks.
- You are not currently in a severe psychotic episode, not suicidal, and not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psychotherapy can help people with schizophrenia or schizotypal disorder who have problems with their sense of self. It aims to improve well-being and daily functioning. If you have completed the OPUS program and are in F-ACT care, you may be able to join.
This trial tests whether oxytocin, a hormone that helps with social bonding and stress, can improve anxiety or emotional awareness in people with central diabetes insipidus (a condition where the body can't regulate water balance). It may be a good fit if you have high anxiety or trouble identifying your feelings.
This trial tests whether a yoga-based group program can help people with schizophrenia spectrum disorders feel better. It's designed for outpatients who are stable enough to participate in group therapy.
This trial studies whether a structured group yoga program can help people who are currently receiving care for schizophrenia-spectrum disorders. It focuses on patients with low-to-moderate current psychosis and aims to add a supportive therapy alongside usual treatment.
This study explores whether being with a friendly dog and getting a nasal spray of oxytocin (a natural hormone) can help you feel more trust toward a therapist. It's looking for healthy adults who are comfortable around dogs.
This trial tests a group therapy program called the Feeling Safe Programme for people with psychosis. It aims to help you learn new ways to cope with your symptoms and feel safer. It meets once a week for 75 minutes.
Hear when a new Schizophrenia Spectrum Disorders (SSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.